The world is on track to miss its health targets

The world is failing its health report card. Despite decades of progress, global efforts to combat infectious diseases are stalling—or even backsliding. The World Health Organization’s latest global health statistics report, published in 2026, delivers a sobering verdict: we are not on track to meet the United Nations’ Sustainable Development Goals (SDGs) for health by 2030. These ambitious targets, set in 2015, were designed to transform global well-being—ending epidemics, ensuring universal health coverage, and dramatically reducing deaths from preventable diseases. But with only four years left until the deadline, the data paints a troubling picture: progress is uneven, inconsistent, and in some cases, moving in the wrong direction.

The SDGs represent one of the most comprehensive global health agendas ever conceived. Spanning 17 interconnected goals, they aim to eradicate poverty, combat climate change, promote gender equality, and—critically—ensure healthy lives and well-being for all. Yet, as the 2026 report reveals, the world is falling short on key health metrics. While some regions have made strides, others are being left behind, and the overall pace of improvement is too slow to meet the 2030 targets. The consequences are not just statistical—they are measured in lives lost, communities destabilized, and healthcare systems overwhelmed.

Among the most alarming trends is the resurgence of diseases once thought to be on the brink of control. HIV, tuberculosis, and malaria—three of the world’s deadliest infectious diseases—are not only persisting but, in some cases, expanding. These setbacks underscore a deeper crisis: the fragility of global health gains in the face of conflict, climate change, and systemic inequities. As we examine the data, it becomes clear that achieving the SDGs will require more than medical innovation—it demands political will, sustained investment, and a commitment to equity.

HIV: A Preventable Epidemic Still Spreading

In 2024, an estimated 1.3 million people were newly infected with HIV. That’s a staggering number—equivalent to the entire population of a mid-sized European country like Estonia or Cyprus. While this figure represents a 40% decline since 2010, it falls far short of the SDG target to reduce new infections by 90% by 2030. The goal was not just ambitious—it was achievable. After all, the world had already made significant progress under the earlier Millennium Development Goals, successfully halting and reversing the spread of HIV by 2015.

Today, however, the momentum has stalled. Sub-Saharan Africa remains the epicenter of the epidemic, accounting for nearly 70% of new infections. Young women and girls are particularly vulnerable, with adolescent girls and young women facing infection rates up to eight times higher than their male peers in some regions. This disparity is not biological—it’s structural. Gender inequality, limited access to education, and economic dependence make it harder for women to negotiate safe sex or access prevention tools like pre-exposure prophylaxis (PrEP).

The tools to end HIV exist. Effective prevention methods, including PrEP, male circumcision, and harm reduction programs for people who inject drugs, have proven successful in high-income countries. Yet, in many low- and middle-income nations, these interventions remain out of reach due to cost, stigma, and weak health systems. The global response has also been hampered by funding shortfalls. International aid for HIV has plateaued, even as new challenges—like the rise of drug-resistant strains—emerge.

Tuberculosis: The Forgotten Pandemic

If HIV is a persistent crisis, tuberculosis (TB) is a silent one. Ranking as the 10th leading cause of death globally, TB kills more people each year than HIV/AIDS and malaria combined. The disease, caused by a bacterium that primarily attacks the lungs, is both preventable and curable—yet it continues to ravage communities, especially in overcrowded, under-resourced settings.

The SDG target was to reduce TB incidence by 80% between 2015 and 2030. So far, we’ve only achieved a 12% decline. Worse, some regions are moving backward. The Americas saw a 13% increase in TB cases in 2024, driven by rising poverty, migration, and healthcare disruptions. In countries like Venezuela and Haiti, collapsing health systems have left millions without access to diagnosis or treatment.

Drug-resistant TB is an especially growing concern. Multidrug-resistant TB (MDR-TB) does not respond to the two most powerful first-line antibiotics, requiring longer, more toxic, and far more expensive treatment regimens. In 2024, an estimated 500,000 new cases of drug-resistant TB were reported—a number that has more than doubled since 2015. The rise of extensively drug-resistant TB (XDR-TB), which is resistant to even more drugs, threatens to undo decades of progress.

Why Is TB So Hard to Eliminate?

TB thrives in conditions of poverty, malnutrition, and poor ventilation. It spreads easily in crowded homes, prisons, and refugee camps. But the real challenge lies in detection and treatment. Many people with TB do not show symptoms for months or even years, allowing the disease to spread silently. When symptoms do appear—chronic cough, fever, weight loss—they are often mistaken for other illnesses.

Diagnosis remains a bottleneck. While molecular tests like GeneXpert have revolutionized TB detection, they are still not widely available in rural or conflict-affected areas. Treatment is equally challenging. The standard six-month regimen requires daily medication, and many patients drop out due to side effects, stigma, or economic hardship.

Malaria: A Disease on the Rise

Malaria, transmitted by infected mosquitoes, is one of humanity’s oldest scourges. Yet, despite being preventable and treatable, it remains a major killer—especially among children under five in sub-Saharan Africa. The SDG target was to reduce malaria incidence by 90% by 2030. Instead, in 2024, the world saw an 8.5% increase in cases, with an estimated 282 million infections globally.

This reversal is particularly alarming because malaria had been on a steady decline for over a decade. Between 2000 and 2015, global malaria deaths fell by 60%, thanks to widespread use of insecticide-treated bed nets, rapid diagnostic tests, and artemisinin-based combination therapies (ACTs). But progress has since plateaued—and in some areas, reversed.

Climate change is a major driver. Rising temperatures and erratic rainfall patterns are expanding the geographic range of malaria-carrying mosquitoes. Regions that were once too cool or dry for transmission are now becoming hospitable. In Ethiopia and Kenya, highland areas previously free of malaria are now reporting outbreaks.

Resistance is another growing threat. Mosquitoes are developing resistance to common insecticides, and the malaria parasite is becoming less responsive to artemisinin—the cornerstone of modern treatment. In Southeast Asia, partial resistance to artemisinin has already led to treatment failures, raising fears of a global spread.

The good news? Innovation is offering new hope. The RTS,S and R21 malaria vaccines, rolled out in several African countries, have shown promising results in reducing severe cases in children. In 2024, over 12 million doses were administered, preventing an estimated 13,000 child deaths. But vaccine coverage remains low, and logistical challenges—like cold storage and delivery to remote areas—limit widespread impact.

The Bigger Picture: Why Are We Falling Short?

The failure to meet global health targets cannot be blamed on a single factor. It is the result of a complex interplay of political, economic, and social forces. One major issue is funding. While international health aid has increased over the past two decades, it has not kept pace with need. The Global Fund to Fight AIDS, Tuberculosis and Malaria, a key financier of disease programs, faces a $3 billion annual shortfall.

Moreover, health systems in many low-income countries remain weak and under-resourced. Health worker shortages, poor infrastructure, and lack of essential medicines undermine even the best-designed programs. In conflict zones like Yemen and Sudan, health facilities are often destroyed or inaccessible, leaving millions without care.

Another critical factor is inequality. The burden of disease falls disproportionately on the world’s poorest and most marginalized populations. Women, children, refugees, and ethnic minorities often face barriers to healthcare due to discrimination, distance, or cost. The COVID-19 pandemic exacerbated these disparities, diverting resources and disrupting routine health services.

Finally, there is a lack of political prioritization. While leaders routinely pledge support for global health, domestic budgets often tell a different story. In many countries, defense spending far exceeds health investment. Without sustained political will, even the most effective interventions will fail to scale.

The Path Forward: What Must Be Done?

Meeting the 2030 health targets is still possible—but it will require a dramatic shift in approach. First, funding must increase and be more equitably distributed. Donor countries must honor their commitments, and low-income nations must prioritize health in national budgets.

Second, health systems must be strengthened from the ground up. This means training more health workers, improving supply chains, and investing in primary care. Digital health tools—like telemedicine and mobile diagnostics—can help bridge gaps in access.

Third, innovation must be accelerated. New vaccines, diagnostics, and treatments are essential—but so is ensuring they reach the people who need them most. Intellectual property barriers and high drug prices must be addressed to make medicines affordable.

Ultimately, achieving the SDGs will require a collective effort. Governments, NGOs, the private sector, and communities must work together. The tools exist. The knowledge is there. What’s missing is the will to act—before it’s too late.

This article was curated from The world is on track to miss its health targets via MIT Technology Review